Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sucampo Pharmaceuticals SCMP

Healthcare Drug Manufacturers - Specialty & Generic
"Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development... see more

Recent & Breaking News (NDAQ:SCMP)

15 Biggest Mid-Day Losers For Tuesday

Benzinga.com  October 3, 2017

Sucampo Pharmaceuticals Announces FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation

GlobeNewswire September 28, 2017

Sucampo Pharmaceuticals Announces Presentation at Deutsche Bank’s 25th Annual Leveraged Finance Conference

GlobeNewswire September 27, 2017

Drug Makers Stock Performance Review -- Apricus Biosciences, DURECT, Sucampo Pharma, and Depomed

PR Newswire September 26, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

GlobeNewswire September 21, 2017

Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel

GlobeNewswire September 20, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 19, 2017

Cancer Prevention Pharmaceuticals Receives $9.5 Million in Additional Funding from Sucampo Following Phase 3 Trial Progress

Business Wire September 11, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Wells Fargo Healthcare Conference

GlobeNewswire August 30, 2017

12 Biggest Mid-Day Gainers For Monday

Benzinga.com  August 21, 2017

Drug Makers Stock Performance Review -- DURECT, Sucampo Pharma, Apricus Biosciences, and MEI Pharma

PR Newswire August 7, 2017

Sucampo Reports Second Quarter 2017 Financial Results

GlobeNewswire August 2, 2017

Investor Network: Sucampo Pharmaceuticals, Inc. to Host Earnings Call

Accesswire August 2, 2017

Sucampo Announces Second Quarter 2017 Earnings Call

GlobeNewswire July 19, 2017

Dr. Karen Smith Joins Sucampo’s Board of Directors

GlobeNewswire July 18, 2017

Daily Technical Summary Reports on Drug Makers Stocks -- Apricus Biosciences, DURECT, Sucampo Pharma, and SciClone Pharma

PR Newswire June 28, 2017

Sucampo Pharmaceuticals Announces Issuance of New Patent for VTS-270

GlobeNewswire June 13, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2017 Global Healthcare Conference

GlobeNewswire June 1, 2017

Technical Reports on Drug Makers Stocks -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma

PR Newswire May 22, 2017

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2017 Health Care Conference

GlobeNewswire May 11, 2017